Propofol
Propofol-Lipuro B. Braun Melsungen, Propofol Mct Baxter, Propofol Mit Mct Fresenius · ATC code N01AX10
Brand names: Disoprivan, Propofol Baxter, Propofol Bioq Pharma, Propofol Farmak, Propofol Fresenius, Propofol-Lipuro B. Braun Melsungen, Propofol Mct Baxter, Propofol Mct Fresenius, Propofol Mit Mct Fresenius, Centropol, Paisofol
- Key facts
- Active substance
- Propofol
- ATC code
- N01AX10
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-11-06
Key facts
Propofol is a short-acting intravenous hypnotic in a lipid emulsion. Per the US label it is used for induction and maintenance of general anaesthesia, procedural (MAC) sedation and ICU sedation of ventilated adults.
What it is used for
- Induction of general anaesthesia from 3 years of age; maintenance from 2 months of age
- Initiation and maintenance of monitored anaesthesia care (MAC) sedation in adults, and sedation with regional anaesthesia
- ICU sedation of intubated, mechanically ventilated adults (not paediatric ICU sedation)
Dosing
- Induction, adults under 65 years (ASA-PS I or II): 2 mg/kg to 2.5 mg/kg titrated to effect; elderly, debilitated or ASA-PS III or IV: about 1 mg/kg to 1.5 mg/kg, no rapid bolus
- Induction, children 3 years through 16 years: 2.5 mg/kg to 3.5 mg/kg
- Maintenance in adults: 100 mcg/kg/min to 200 mcg/kg/min with nitrous oxide, reduced 30% to 50% during the first half-hour
- MAC sedation: usually 25 mcg/kg/min to 75 mcg/kg/min after slow initiation
- ICU sedation: start at 5 mcg/kg/min, increase by 5 mcg/kg/min to 10 mcg/kg/min at least 5 minutes apart; usual maintenance 5 mcg/kg/min to 50 mcg/kg/min; do not exceed 4 mg/kg/hour unless benefits outweigh risks
- Strict asepsis: use within 12 hours of opening and discard tubing and remainder after 12 hours
Contraindications
- Hypersensitivity to propofol or any component
- History of anaphylaxis to eggs, egg products, soybeans or soy products
Important warnings
- Only by staff trained in anaesthesia, with airway, ventilation and resuscitation equipment at hand; hypotension, apnoea and desaturation are more likely after rapid bolus
- Propofol infusion syndrome in ICU sedation (metabolic acidosis, hyperkalaemia, rhabdomyolysis, renal and cardiac failure), sometimes fatal
- Bradycardia, asystole and rarely cardiac arrest (no vagolytic activity), especially in children given fentanyl
- Fatal and life-threatening anaphylactic reactions; seizure risk in epileptic patients during recovery
- Microbial contamination of the emulsion if asepsis is not maintained
Side effects
- Hypotension, bradycardia, arrhythmias
- Apnoea, cough, upper airway obstruction, hypoventilation
- Movement, hypertonia, agitation, abnormal dreams
- Nausea, hypersalivation; injection-site pain
- ICU: hyperlipidaemia, decreased cardiac output
Interactions
- Opioids, benzodiazepines and other sedatives: lower induction dose and greater falls in blood pressure and cardiac output
- Fentanyl in children: serious bradycardia
- Inhalational agents and nitrous oxide increase anaesthetic and cardiorespiratory effects
- Valproate: higher propofol levels; reduce the propofol dose
Pregnancy and breastfeeding
- Decades of data, mostly at caesarean delivery, show no drug-associated risk of major birth defects or miscarriage; neonatal depression reported after exposure during delivery
- Present in human milk; no adverse reactions shown in breastfed infants
Summary of the official product information, written with AI on 2026-11-14. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Germany
- DisoprivanAspen Pharma Trading Limited · 1 register entry
- Propofol BaxterBaxter Holding B.V. · 1 register entry
- Propofol Bioq PharmaBioq Pharma B.V. · 1 register entry
- Propofol FarmakAspire Pharma (Malta) Limited · 1 register entry
- Propofol FreseniusFresenius Kabi Deutschland Gmbh · 1 register entry
- Propofol-Lipuro B. Braun MelsungenB.Braun Melsungen Ag · 1 register entry
- Propofol Mct BaxterBaxter Holding B.V. · 1 register entry
- Propofol Mct FreseniusFresenius Kabi Deutschland Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-06
Austria
- Propofol-Lipuro B. Braun MelsungenB.Braun Melsungen Ag · 1 register entry
- Propofol Mct BaxterBaxter Holding B.V. · 1 register entry
- Propofol Mit Mct FreseniusFresenius Kabi Austria Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-11-06
Turkey
- CentropolCENTURİON İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
- PaisofolAROMA İLAÇ SAN. LTD. ŞTİ. · 1 register entry
- PropofolİDE İLAÇ RUHSATLANDIRMA BİYOFARMASÖTİK DANIŞMANLIK EĞİTİM VE MÜMESSİLLİK HİZMETLERİ DIŞ TİCARET İTHALAT İHRACAT LTD. ŞTİ., ADEKA İLAÇ SAN. VE TİC. A.Ş., HAVER FARMA İLAÇ A.Ş., VEM İLAÇ SAN. VE TİC. A.Ş., POLİFARMA İLAÇ SAN. VE TİC. A.Ş. · 16 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-11-06
Brand names in 27 more European countries
- Belgium
- Diprivan, Propofol B. Braun, Propolipid
- Bulgaria
- Propofol Mct/Lct Fresenius, Пропофол-Липуро B. Braun Melsungen, Пропофол Пф, Пропофол Ромфарм, Профол
- Croatia
- Propofol-Lipuro B. Braun Adria, Propofol Mct Fresenius
- Cyprus
- Hiremon, Propofol-Lipuro B. Braun Melsungen, Propofol Mct/Lct Fresenius
- Czechia
- Anesia Baxter, Propofol Baxter, Propofol-Lipuro B. Braun Melsungen, Propofol Mct Fresenius, Propofol Mct/Lct Fresenius
- Denmark
- Profast, Propofol B. Braun, Propolipid
- Estonia
- Anesia, Propofol-Lipuro B. Braun Melsungen, Propoven
- Finland
- Profast, Propofol-Lipuro B. Braun Melsungen, Propolipid
- France
- Diprivan, Propofol Baxter, Propofol Bioq, Propofol Kabi, Propofol Lipuro B Braun Melsungen
- Greece
- Hiremon, Propofol Baxter, Propofol-Lipuro B. Braun Melsungen, Propofol Mct/Lct /Fresenius, Propofol Mct/Lct Fresenius
- Hungary
- Anesia, Propofol Mct Fresenius, Propofol Mct/Lct Fresenius
- Iceland
- Propolipid
- Ireland
- Diprivan, Propofol
- Italy
- Diprivan, Propofol B. Braun, Propofol Kabi, Rapiva, Ripol, Unifol
- Latvia
- Anesia, Propofol-Lipuro B. Braun Melsungen, Propoven
- Lithuania
- Anesia, Propofol-Lipuro B. Braun Melsungen, Propoven
- Luxembourg
- Diprivan, Propofol Baxter, Propofol-Lipuro B. Braun Melsungen, Propolipid
- Malta
- Propofol
- Netherlands
- Diprivan-10, Diprivan-20, Propofol Baxter, Propofol Bioq Pharma, Propofol-Lipuro B. Braun Melsungen, Propofol-Lipuro B.Braun Melsungen, Propofol Mct/Lct Fresenius, Propofol Spiva
- Norway
- Profast, Propofol-Lipuro B. Braun Melsungen, Propolipid
- Poland
- Diprivan, Plofed, Propofol Baxter, Propofol Farmak, Propofol-Lipuro B. Braun Melsungen, Propofol Mct/Lct Fresenius
- Portugal
- Propofol Baxter, Propofol Demo, Propofol Fresenius, Propofol-Lipuro B. Braun Melsungen, Propofol Mct/Lct Fresenius
- Romania
- Profast, Propofol-Lipuro B.Braun Melsungen, Propofol Mct/Lct Fresenius, Propofol Rompharm
- Slovakia
- Propofol-Lipuro B. Braun Melsungen, Propofol Mct Fresenius, Propofol Mct/Lct Fresenius
- Slovenia
- Anesia, Propofol Baxter, Propofol-Lipuro B. Braun Melsungen, Propoven
- Spain
- Diprivan, Propofol Baxter, Propofol Farmak, Propofol Lipoven Fresenius, Propofol Lipuro B. Braun Melsungen
- Sweden
- Diprivan, Profast, Propofol-Lipuro B. Braun Melsungen, Propofol Sandoz, Propolipid
EMA – Article 57 product data (EU/EEA), 2026-11-06
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. Propofol (Civica, Inc) – Prescribing Information, 2026-09-18. DailyMed (NLM), 2026-11-06. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ba70032-40c2-41c5-9f99-d1f94032d3dc
- EMA – Article 57 product data (EU/EEA), 2026-11-06. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-11-06. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-11-06. https://www.titck.gov.tr/dinamikmodul/85
Editorial: Medelix editorial team · last updated 2026-11-06 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.